Search

Shaun L Gammill

from Houston, TX

Shaun Gammill Phones & Addresses

  • 3838 N Braeswood Blvd APT 146, Houston, TX 77025 (512) 461-1196
  • 3838 N Braeswood Blvd APT 146, Houston, TX 77025

Work

Company: Plx pharma inc. Apr 2017 to May 2019 Position: Director of production and engineering

Skills

Pharmaceutical Industry • Gmp • Life Sciences • Sop • Biotechnology • Fda

Industries

Pharmaceuticals

Resumes

Resumes

Shaun Gammill Photo 1

Shaun Gammill

View page
Location:
Marble Falls, TX
Industry:
Pharmaceuticals
Work:
Plx Pharma Inc. Apr 2017 - May 2019
Director of Production and Engineering
Skills:
Pharmaceutical Industry
Gmp
Life Sciences
Sop
Biotechnology
Fda

Publications

Us Patents

Ph Dependent Carriers For Targeted Release Of Pharmaceuticals Along The Gastrointestinal Tract, Compositions Therefrom, And Making And Using Same

View page
US Patent:
20130090313, Apr 11, 2013
Filed:
Sep 29, 2012
Appl. No.:
13/631963
Inventors:
PLX Pharma Inc. - Houston TX, US
Susann Edler Childress - Houston TX, US
Shaun L. Gammill - Houston TX, US
Robert W. Strozier - Houston TX, US
Assignee:
PLX PHARMA INC. - Houston TX
International Classification:
A61K 47/24
A61K 47/12
A61K 31/196
A61K 31/60
A61K 31/192
A61K 31/405
A61K 31/616
A61K 47/14
US Classification:
514165, 514784, 514159, 514569, 514420, 514567
Abstract:
Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (FFA) are able to deliver biologically active agents to various pH environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious to the upper GI tract (esophagus, stomach, and duodenum), (b) acid labile, (c) impermeable/insoluble compounds in GI fluids, (d) susceptible to first pass metabolism, and/or (e) cause stomach irritation, upset, or dyspepsia.

Ph Dependent Carriers For Targeted Release Of Pharmaceuticals Along The Gastrointestinal Tract, Compositions Therefrom, And Making And Using Same

View page
US Patent:
20200222309, Jul 16, 2020
Filed:
Mar 27, 2020
Appl. No.:
16/833371
Inventors:
- Sparta NJ, US
Susann Childress - Houston TX, US
Shaun Gammill - Houston TX, US
Robert W. Strozier - Houston TX, US
Assignee:
PLx Opco Inc. - Sparta NJ
International Classification:
A61K 9/00
A61K 45/06
A61K 9/48
A61K 31/192
A61K 31/196
A61K 31/405
A61K 31/60
A61K 31/616
A61K 47/12
A61K 47/14
A61K 47/24
Abstract:
Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (FFA) are able to deliver biologically active agents to various pH environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious to the upper GI tract (esophagus, stomach, and duodenum), (b) acid labile, (c) impermeable/insoluble compounds in GI fluids, (d) susceptible to first pass metabolism, and/or (e) cause stomach irritation, upset, or dyspepsia.

Ph Dependent Carriers For Targeted Release Of Pharmaceuticals Along The Gastrointestinal Tract, Compositions Therefrom, And Making And Using Same

View page
US Patent:
20190070099, Mar 7, 2019
Filed:
Nov 7, 2018
Appl. No.:
16/183616
Inventors:
- Houston TX, US
Susann Edler Childress - Houston TX, US
Shaun L. Gammill - Houston TX, US
Robert W. Strozier - Houston TX, US
Assignee:
PLx Opco Inc. - Houston TX
International Classification:
A61K 9/00
A61K 9/48
A61K 45/06
A61K 31/616
A61K 31/60
A61K 47/12
A61K 31/196
A61K 31/192
A61K 47/24
A61K 47/14
A61K 31/405
Abstract:
Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (FFA) are able to deliver biologically active agents to various pH environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious to the upper GI tract (esophagus, stomach, and duodenum), (b) acid labile, (c) impermeable/soluble compounds in GI fluids, (d) susceptible to first pass metabolism, and/or (e) cause stomach irritation, upset, or dyspepsia.

Ph Dependent Carriers For Targeted Release Of Pharmaceuticals Along The Gastrointestinal Tract, Compositions Therefrom, And Making And Using Same

View page
US Patent:
20170304190, Oct 26, 2017
Filed:
Jul 7, 2017
Appl. No.:
15/644694
Inventors:
- Houston TX, US
Susann Edler CHILDRESS - Houston TX, US
Shaun L. GAMMILL - Houston TX, US
Robert W. STROZIER - Houston TX, US
Assignee:
PLx Opco Inc. - Houston TX
International Classification:
A61K 9/00
A61K 47/14
A61K 47/12
A61K 45/06
A61K 31/616
A61K 31/60
A61K 31/405
A61K 31/196
A61K 31/192
A61K 47/24
A61K 9/48
Abstract:
Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (FFA) are able to deliver biologically active agents to various pH environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious to the upper GI tract (esophagus, stomach, and duodenum), (b) acid labile, (c) impermeable/insoluble compounds in GI fluids, (d) susceptible to first pass metabolism, and/or (e) cause stomach irritation, upset, or dyspepsia.

Ph Dependent Carriers For Targeted Release Of Pharmaceuticals Along The Gastrointestinal Tract, Compositions Therefrom, And Making And Using Same

View page
US Patent:
20140094439, Apr 3, 2014
Filed:
Jun 3, 2013
Appl. No.:
13/908233
Inventors:
- Houston TX, US
Susann Edler Childress - Houston TX, US
Shaun L. Gammill - Houston TX, US
Robert W. Strozier - Houston TX, US
International Classification:
A61K 47/24
A61K 31/196
A61K 31/192
A61K 31/405
A61K 31/616
A61K 31/60
US Classification:
514165, 514159, 514569, 514420, 514567
Abstract:
Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (FFA) are able to deliver biologically active agents to various pH environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious to the upper GI tract (esophagus, stomach, and duodenum), (b) acid labile, (c) impermeable/insoluble compounds in GI fluids, (d) susceptible to first pass metabolism, and/or (e) cause stomach irritation, upset, or dyspepsia.

Ph Dependent Carriers For Targeted Release Of Pharmaceuticals Along The Gastrointestinal Tract, Compositions Therefrom, And Making And Using Same

View page
US Patent:
20140094526, Apr 3, 2014
Filed:
Mar 8, 2013
Appl. No.:
13/791189
Inventors:
- Houston TX, US
Susann Edler Childress - Houston TX, US
Shaun L. Gammill - Houston TX, US
Robert W. Strozier - Houston TX, US
Assignee:
PLX PHARMA INC. - Houston TX
International Classification:
A61K 9/00
US Classification:
514784
Abstract:
Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (FFA) are able to deliver biologically active agents to various pH environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious to the upper GI tract (esophagus, stomach, and duodenum), (b) acid labile, (c) impermeable/insoluble compounds in GI fluids, (d) susceptible to first pass metabolism, and/or (e) cause stomach irritation, upset, or dyspepsia.
Shaun L Gammill from Houston, TX Get Report